The Cost and Efficacy of Home Care for Patients With Chronic Lung Disease

A randomized controlled trial was conducted to assess efficacy and cost of sustained home nursing care for patients with chronic lung disease. Three hundred one patients were randomly assigned to a respiratory home care group (RHC) that received care from respiratory home care nurses, a standard home care group (SHC) that received care from regular home care nurses, or an office care group (OC) that received whatever care they needed except for home care. Patients were followed for 1 year. At the end of the study year, there was no difference in survival, pulmonary function, or everyday functioning among the three groups. Average annual cost of care for all study patients was $7,647 (1981-82 dollars). The average annual health care costs for patients in the RHC group was $9,768; for those in the SHC group, $8,058; and for those in the OC group, $5,051 (F = 6.45, df = 2/298, P = 0.02). These results suggest that the current policy of limited coverage of home nursing services by Medicare and other third-party payers may be appropriate

Clinical trial · Family medicine · Health care · Intensive care medicine · Randomized controlled trial · Respiratory care · Chronic Disease Management Strategies · Emergency and Acute Care Studies · Emergency Medicine · Geriatric Care and Nursing Homes · Internal Medicine · Medicine · Nursing

• Generic and Disease-Specific Measures in Assessing Health Status and Quality of Life

  Donald L Patrick, Richard A Deyo•Medical Care•1989

  Incluir item

• Measuring Functional Change in Community-Acquired Pneumonia

  Peggy B Hasley, Frederick L Brancati et al.•Medical Care•1993

  Incluir item

• The Sickness Impact Profile as a Measure of the Health Status of Noncognitively Impaired Nursing Home Residents

  Margaret L Rothman, Margaret Rothman et al.•Medical Care•1989

  Incluir item

• Meta-analysis of Home-Care Effects on Mortality and Nursing-Home Placement

  Susan C Hedrick, Thomas D Koepsell et al.•Medical Care•1989

  Incluir item

• Determining Clinically Important Differences in Health Status Measures

  Open Access•Greg Samsa, David Edelman et al.•PharmacoEconomics•1999

  Incluir item

• Economic appraisal of asthma and COPD care

  Open Access•Maureen P M H, RUTTEN-VAN MÖLKEN et al.•Social Science & Medicine•1992

  Incluir item

• Cost-effectiveness of alpha-1 antitrypsin replacement therapy in treatment of congenital chronic obstructive pulmonary disease

  Joel W Hay, Eugene D Robin•American Journal of Public Health•1991

  Incluir item

• The Montefiore Hospital Home Care Program

  Martín Cherkasky•American Journal of Public Health…•1949

  Incluir item

• Health status of survivors of out-of-hospital cardiac arrest six months later

  Lawrence Bergner, Marilyn Bergner et al.•American Journal of Public Health•1984

  Incluir item

• The Sickness Impact Profile

  Marilyn Bergner, Ruth A Bobbitt et al.•Medical Care•1981

  Incluir item

• Effects and Costs of Day-Care Services for the Chronically Ill

  William G Weissert, William Weissert et al.•Medical Care•1980

  Incluir item